You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 9, 2024

Acetaminophen; ibuprofen - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

What are the generic drug sources for acetaminophen; ibuprofen and what is the scope of patent protection?

Acetaminophen; ibuprofen is the generic ingredient in five branded drugs marketed by Bionpharma, Granules, L Perrigo Co, Marksans Pharma, Aurobindo Pharma Ltd, Haleon Us Holdings, Aft Pharms Ltd, and Hikma, and is included in eight NDAs. There are eight patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Acetaminophen; ibuprofen has sixty patent family members in thirty-two countries.

Thirty-six suppliers are listed for this compound.

Summary for acetaminophen; ibuprofen

International Patents:	60
US Patents:	8
Tradenames:	5
Applicants:	8
NDAs:	8
Finished Product Suppliers / Packagers:	36
Clinical Trials:	235
DailyMed Link:	acetaminophen; ibuprofen at DailyMed

Recent Clinical Trials for acetaminophen; ibuprofen

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Kyongbo Pharmaceutical Co.,Ltd	Phase 4
Korea University Guro Hospital	Phase 4
Novo Nordisk A/S	Phase 1

See all acetaminophen; ibuprofen clinical trials

Pharmacology for acetaminophen; ibuprofen

Drug Class	Nonsteroidal Anti-inflammatory Drug
Mechanism of Action	Cyclooxygenase Inhibitors

Anatomical Therapeutic Chemical (ATC) Classes for acetaminophen; ibuprofen

US Patents and Regulatory Information for acetaminophen; ibuprofen

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hikma	COMBOGESIC IV	acetaminophen; ibuprofen sodium	SOLUTION;INTRAVENOUS	215320-001	Oct 17, 2023		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial	Y			⤷ Try a Trial
Hikma	COMBOGESIC IV	acetaminophen; ibuprofen sodium	SOLUTION;INTRAVENOUS	215320-001	Oct 17, 2023		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Aurobindo Pharma Ltd	ACETAMINOPHEN; IBUPROFEN	acetaminophen; ibuprofen	TABLET;ORAL	218359-001	Mar 26, 2024		OTC	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for acetaminophen; ibuprofen

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Title	Estimated Expiration
Ecuador	SP21072036	COMPOSICIÓN FARMACÉUTICA QUE CONTIENE ACETAMINOFENO E IBUPROFENO	⤷ Try a Trial
Mexico	2021016089	COMPOSICIÓN NOVEDOSA DE IBUPROFENO Y ACETAMINOFENO. (NOVEL IBUPROFEN AND ACETAMINOPHEN COMPOSITION.)	⤷ Try a Trial
South Korea	20070034614		⤷ Try a Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Supplementary Protection Certificates for acetaminophen; ibuprofen

Subscribe to access the full database, or Try a Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1781277	PA2024501	Lithuania	⤷ Try a Trial	PRODUCT NAME: IBUPROFENO IR PARACETAMOLIO DERINYS; REGISTRATION NO/DATE: LT/1/23/5212/001-002 20230726
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.